- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr John Fox Discusses Expanding Comprehensive Genomic Profiling Across Several Cancers
John Fox, MD, MHA, vice president of Clinical Transformation at Spectrum Health, reacts to the National Comprehensive Cancer Network's call to expand comprehensive genomic testing across several cancers.
John Fox, MD, MHA, vice president of cinical transformation at Spectrum Health, reacts to the National Comprehensive Cancer Network's (NCCN's) call to expand comprehensive genomic testing across several cancers.
Transcript
At the most recent NCCN Annual Meeting, guidelines called for expanded comprehensive molecular profiling across several cancers. Do these changes present new reimbursement challenges?
The NCCN has recommended that we do comprehensive molecular profiling on more and more cancer types. It’s fascinating because the cost of genomic profiling is now in the range of $2500 to $3000. If you look at the cost of the therapies we’re using, they may be, if you’re using a monoclonal antibody, $8000, $10,000, $15,000 a month, and if we’re using those in combination, it’s even more. So, if in fact those molecular profiles help better identify which patients are likely to respond to which therapies, it’s a good value, because they’re spending thousands, tens of thousands of dollars a month on treatment, that if ineffective, is a waste of dollars and a waste of resources and a cost to the patient.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Dermatologists Advocating for Inclusive Hair Loss Research and Treatment in the African Diaspora
March 26th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, advocates for increased funding and education to address hair loss disparities within the African diaspora, emphasizing the need for culturally sensitive treatment and research.
Read More
